Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections

NCT00463801 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

52

Enrollment

INDUSTRY

Sponsor class

Stopped Because of inadequate accrual.

Conditions

Staphylococcal Skin Infections

Interventions

DRUG: Daptomycin

Sponsor

Novartis